RFK Jr.'s appointment as HHS Secretary is creating pressure as Medicare price setting and Part D redesign impact the sales and operations of major pharmaceutical companies including Pfizer, Amgen, J&J, Merck, and Eli Lilly.

The entities involved

• Robert F. Kennedy Jr. →

  American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)

  • Robert F. Kennedy Jr. visited Clinton Township to announce funding as part of Donald Trump's Great American Recovery Initiative.Mon 08:37
  • An outbreak in Lancaster County, Pennsylvania, has drawn comments from officials regarding vaccine policy, involving figures like Robert F. Kennedy Jr. and those connected to Donald Trump.Mon 06:20
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
• Amgen →

  American multinational biopharmaceutical company

  • Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04

Related events

• Robert F. Kennedy Jr. served as health secretary for HHS and was involved in FDA leadership decisions.Jun 12
• RFK Jr. praised Trump's administration regarding drug pricing policy, while Trump used Biden's administration as a political contrast.Sep 2
• HHS policy statement includes comments from Robert F. Kennedy Jr.Jul 29
• The Administration negotiated confidential deals on drug prices using HHS officials, involving major pharmaceutical companies.Sep 19
• Medicare pricing negotiations are impacting major pharmaceutical companies, including AbbVie, Eli Lilly, and Merck, who are seeking pricing exemptions.Jun 21